DEXA Scan (Body Composition)

DEXA scanning represents the gold standard for body composition analysis, offering unparalleled precision in measuring bone density, muscle mass, and fat distribution. Research indicates that DEXA-derived metrics strongly correlate with longevity outcomes, particularly appendicular lean mass index for sarcopenia assessment and visceral adipose tissue quantification for metabolic risk stratification. The technology provides detailed regional analysis, enabling tracking of age-related changes in body composition that influence healthspan and mortality risk.

Studies suggest that regular DEXA monitoring can identify early sarcopenia, osteoporosis risk, and metabolic dysfunction before clinical symptoms appear. The scan's ability to distinguish visceral from subcutaneous fat provides valuable insights into cardiovascular risk and insulin sensitivity. Research demonstrates that individuals with higher appendicular lean mass and lower visceral adipose tissue, as measured by DEXA, show improved longevity outcomes and reduced age-related disease risk.

While primarily used clinically for osteoporosis screening, DEXA scanning has become increasingly valuable for longevity-focused health optimization. The low radiation exposure and non-invasive nature make it suitable for periodic monitoring, with many longevity practitioners recommending annual or biannual scans to track body composition changes over time. The detailed data enables precise assessment of intervention effectiveness and early detection of age-related physiological decline.